Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years.

Over the past two decades, cell biologists and computational biologists have worked to develop lineage tracing techniques that can decode the ...

Proteomics technologies are expanding rapidly due to advances in mass spectrometry, AI-driven analysis, and single-cell approaches. Growing investment and new applications in drug discovery and ...

The iGE3 Genomics Platform provides access to the state-of-the-art methods in genomic technologies. Our platform provides a seamless, end-to-end solution tailored to your research needs. From ...

Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...

The field of immunology has long recognized immune system dysregulation as a cornerstone of pathogenesis across a range of human diseases, including ...